Jane Street Group, LLC Trillium Therapeutics Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
N/A
-173,761 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
N/A
162,463 Added 1437.98%
173,761 $3.05 Million
Q2 2021

Aug 16, 2021
SELL
N/A
-24,245 Reduced 68.21%
11,298 $109,000
Q1 2021

May 18, 2021
BUY
N/A
21,724 Added 157.2%
35,543 $381,000
Q4 2020

Feb 17, 2021
SELL
N/A
-58,368 Reduced 80.86%
13,819 $204,000
Q3 2020

Nov 17, 2020
BUY
N/A
40,682 Added 129.13%
72,187 $1.03 Million
Q1 2020

May 15, 2020
BUY
N/A
2,917 Added 10.2%
31,505 $124,000
Q4 2019

Feb 14, 2020
BUY
N/A
28,588 New
28,588 $29,000
Q2 2019

Aug 15, 2019
SELL
N/A
-22,494 Closed
0 $0
Q1 2019

May 16, 2019
SELL
N/A
-2,168 Reduced 8.79%
22,494 $14,000
Q4 2018

Feb 15, 2019
BUY
N/A
24,662 New
24,662 $43,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email